切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2020, Vol. 08 ›› Issue (03) : 227 -232. doi: 10.3877/cma.j.issn.2095-5782.2020.03.007

所属专题: 文献

专题研究·眼科介入

面部注射填充术所致视网膜中央动脉栓塞概述
张国栋1, 王峰1,()   
  1. 1. 116011 辽宁大连,大连医科大学附属第一医院介入治疗科
  • 收稿日期:2020-05-23 出版日期:2020-08-25
  • 通信作者: 王峰

An overview of central retinal artery occlusion caused by cosmetic facial filler injection

Guodong Zhang1, Feng Wang1,()   

  1. 1. Department of Interventional Therapy, the First Affiliated Hospital of Dalian Medical University, Liaoning Dalian 116011, China
  • Received:2020-05-23 Published:2020-08-25
  • Corresponding author: Feng Wang
  • About author:
    Corresponding author: Wang Feng,Email:
引用本文:

张国栋, 王峰. 面部注射填充术所致视网膜中央动脉栓塞概述[J/OL]. 中华介入放射学电子杂志, 2020, 08(03): 227-232.

Guodong Zhang, Feng Wang. An overview of central retinal artery occlusion caused by cosmetic facial filler injection[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2020, 08(03): 227-232.

近年来各级医院及美容机构广泛开展面部注射填充术,各种并发症也随之而来,而眼动脉及其分支栓塞所致的失明当属最严重的并发症之一。医源性所致视网膜中央动脉栓塞起病急、进展快,且预后差,易出现视力下降甚至失明,因此预防医源性所致眼动脉及其分支栓塞的发生,及时发现其临床表现和尽早治疗尤为重要。文章通过回顾近年来国内外相关文献,总结了医源性视网膜中央动脉栓塞的临床表现、发病机理及治疗和预后。

With the development of cosmetic facial filler injection in recent years, adverse events and complications related to it have followed, and the most disastrous one is blindness caused by ophthalmic artery and its branch embolization.Due to the sudden onset, rapid progression, poor prognosis and often catastrophic consequences of blindness, it is crucial to realize the clinical manifestations for diagnosis and to deal with these conditions as soon as possible to prevent it from serious consequences.In this paper,the clinical manifestations, pathogenesis, treatment and prognosis were reviewed.

图1 视网膜的动脉血液供应图
[1]
Grory BM, Lavin P, Kirshner H, et al. Thrombolytic therapy for acute central retinal artery occlusion[J]. Stroke, 2019, 51(2), 687-695.
[2]
Carle MV, Roe R, Novack R, et al. Cosmetic facial fillers and severe vision loss[J]. Jama Ophthalmology, 2014, 132(5): 637-639.
[3]
Carruthers JDA, Fagien S, Rohrich R J, et al. Blindness caused by cosmetic filler injection: A review of cause and therapy[J]. Plastic & Reconstructive Surgery, 2014, 134(6): 1197-1201.
[4]
Prasetyo AD, Prager W, Rubin MG, et al. Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: A literature review[J]. Clin Cosmet Investig Dermatol, 2016, 9: 257-280.
[5]
Moradi A, Shirazi A, Perez V. A guide to temporal fossa augmentation with small gel particle hyaluronic acid dermal filler[J]. Journal of Drugs in Dermatology Jdd, 2011, 10(6): 673.
[6]
Edwards AO. Central retinal artery occlusion following forehead injection with a corticosteroid suspension[J]. Pediatric Dermatology, 2010, 25(4): 460-461.
[7]
Beleznay K, Carruthers JDA, Humphrey S, et al. Avoiding and treating blindness from fillers: A review of the world literature[J]. Dermatologic Surgery, 2015, 41(10): 1097-1117.
[8]
Lazzeri D, Agostini T, Figus M, et al. Blindness following cosmetic injections of the face[J]. Plastic & Reconstructive Surgery, 2012, 129(4): 995-1012.
[9]
Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers[J]. Aesthetic Surgery Journal, 2002, 22(6): 555-557.
[10]
Chen Y, Wang W, Li J, et al. Fundus artery occlusion caused by cosmetic facial injections[J]. Chinese Medical Journal, 2014, 127(8): 1434-1437.
[11]
黄慧敏,杨艳峰,侯豹可,等.颜面部美容注射引发眼部并发症解剖分析[J].局解手术学杂志,2016, 25(6): 405-408.
[12]
Sahin I, Isik S. Blindness following cosmetic injections of the face[J]. Plastic and Reconstructive Surgery, 2012, 130(5): 738e.
[13]
Hwang K. Hyperbaric oxygen therapy to avoid blindness from filler injection[J]. J Craniofac Surg, 2016, 27(8): 2154-2155.
[14]
Claudio DL. Complications of injectable fillers, part 2: Vascular complications[J]. Aesthetic Surgery Journal, 2014, 34(4): 584-600.
[15]
Arnold M, Koerner U, Remonda L, et al. Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion[J]. J Neurol Neurosurg Psychiatry, 2005, 76(2): 196-199.
[16]
王润生,雷涛,王毅,等.超选择性眼动脉及选择性颈内动脉溶栓治疗视网膜中央动脉阻塞的疗效观察[J].中华眼底病杂志,2014, 30(5): 450-453.
[17]
Wang HJ, Guay G, Pogan L, et al.Calcium regulates the association between mitochondria and a smooth subdomain of the endoplasmic reticulum[J]. J Cell Biol, 2000, 150(6): 1489-1498.
[18]
Weber J, Remonda L, Mattle H P, et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion[J]. Stroke, 1998, 29(10): 2076-2079.
[19]
Kristian P, Cholevík D, Czerný D, et al. Selective angiography with the possibility of thrombolysis in patients with central retinal artery occlusion[J]. Cesk Slov Oftalmol, 2019, 75: 152-159.
[20]
Kassir R, Kolluru A,Kassir M, et al. Extensive necrosis after injection of hyaluronic acid filler: case report and review of the literature[J]. Journal of Cosmetic Dermatology, 2011, 10(3): 224-231.
[21]
Carruthers J, Fagien S, Dolman P. Retro or periBulbar injection techniques to reverse visual loss after filler injections[J]. Dermatologic Surgery, 2015, 41: S354-S357.
[22]
Chesnut C. Restoration of visual loss with retrobulbar hyaluronidase injection after hyaluronic acid filler[J]. Dermatol Surg, 2017, 44(3): 435-437.
[23]
Fagien S, Carruthers J. Commentary on restoration of visual loss with retrobulbar hyaluronidase injection after hyaluronic acid filler[J]. Dermatologic Surgery, 2017, 44(3): 437-443.
[24]
Sito G, Manzoni V, Sommariva R. Vascular complications after facial filler injection: A literature review and meta-analysis[J]. Journal of Clinical and Aesthetic Dermatology, 2019, 12(6): E65-E72.
[25]
Park SJ, Woo SJ, Park KH, et al. Partial recovery after intraarterial pharmacomechanical thrombolysis in ophthalmic artery occlusion following nasal autologous fat injection[J]. Journal of Vascular & Interventional Radiology Jvir, 2011, 22(2): 251-254.
[26]
Kim YK, Cheolkyu J, Joon W S, et al. Cerebral angiographic findings of cosmetic facial filler-related ophthalmic and retinal artery occlusion[J]. Journal of Korean Medical Science, 2015, 30(12): 1847-1855.
[27]
Kim YJ, Kim SS, Song WK, et al. Ocular ischemia with hypotony after injection of hyaluronic acid gel[J]. Ophthalmic Plastic&Reconstructive Surgery, 2011, 27(6): 152-155.
[28]
Cavallini M, Riccardo G, Marco M, et al. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers[J]. Aesthetic Surgery Journal, 2013, 33(8): 1167-1174.
[29]
Richard G, Lerche RC, Knospe V, et al. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator[J]. Ophthalmology, 1999, 106(4): 768-773.
[30]
Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion[J]. American Journal of Ophthalmology, 1992, 113(4): 429-434.
[31]
Schultheiss M, Florian H, Spitzer MS, et al. Intravenous thrombolysis in acute central retinal artery occlusion-A prospective interventional case series[J]. Plos One, 2018, 13(5): e0198114.
[32]
王润生,吕沛霖,张娅萍,等.以尿激酶静脉溶栓为主治疗视网膜中央动脉阻塞115例临床疗效观察[J].中华眼底病杂志,2012, 28(5): 466-471.
[33]
卢国华,李如龙,王小吟,等.超选择眼动脉溶栓治疗视网膜中央动脉栓塞[J].介入放射学杂志,2006, 15(7): 387-389.
[34]
Schumacher M, Schmidt D, Wakhloo AK. Intra-arterial fibrinolysis in central artery occlusion[J]. Der Radiologe, 1991, 31(5): 240-242.
[35]
Paques M, Vallee JN, Herbreteau D, et al.Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion[J]. British Journal of Ophthalmology, 2000, 84(12): 1387-1391.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[4] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[8] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[9] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 魏志鸿, 刘建勇, 吴小雅, 杨芳, 吕立志, 江艺, 蔡秋程. 肝移植术后急性移植物抗宿主病的诊治(附四例报告)[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 846-851.
[12] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[13] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?